Related Experiment Videos

Possible role of Helicobacter pylori infection via microvascular dysfunction in cardiac syndrome X

Yousef Rasmi1, Sina Raeisi

  • 1Department of Biochemistry, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran. rasmiy@umsu.ac.ir

Cardiology Journal
|December 2, 2009
PubMed

Insights

Helicobacter pylori (H. pylori) infection may cause cardiac syndrome X (CSX) by leading to microvascular dysfunction. This study proposes a link between H. pylori and microvascular dysfunction in CSX development.

Area of Science:

  • Cardiology
  • Gastroenterology
  • Microbiology

Background:

  • Cardiac syndrome X (CSX) is increasingly associated with microvascular dysfunction.
  • Helicobacter pylori (H. pylori), a common cause of gastritis, has been recently linked to CSX.
  • The precise mechanism connecting H. pylori infection to CSX remains unclear.

Purpose of the Study:

  • To investigate the potential role of Helicobacter pylori infection in the development of cardiac syndrome X.
  • To explore the hypothesis that H. pylori-induced microvascular dysfunction contributes to CSX pathogenesis.
  • To elucidate the underlying mechanisms linking H. pylori and CSX.

Main Methods:

  • This study proposes a theoretical link and mechanism.
  • Further research involving patient cohorts and mechanistic studies is warranted.
  • Investigating biomarkers of H. pylori infection and microvascular function in CSX patients.

Main Results:

  • A proposed link between H. pylori infection and microvascular dysfunction in CSX patients.
  • Hypothesized mechanism involving H. pylori leading to microvascular impairment.
  • Suggests H. pylori as a potential contributing factor to CSX.

Conclusions:

  • H. pylori infection may contribute to cardiac syndrome X through microvascular dysfunction.
  • Understanding this link could offer new therapeutic targets for CSX.
  • Further investigation is crucial to confirm the proposed association and mechanism.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...